Citation

87 FR 12968

Multiple canonical documents share this first-page citation.

Prospective Grant of an Exclusive Patent License: NCGC00413972 and Its Related Analogs Consisting of an Imidazo-Pyrazine Scaffold Core for the Treatment or Prevention of Cancers Expressing the Mannose Receptor CD206, Including Both Solid Tumors and Hematological Malignancies Tuesday, March 8, 2022 87 FR 12968
Submission for OMB Review; 30-Day Comment Request Generic Clearance for National Cancer Institute (NCI) NCI Resources, Software and Data Sharing Forms (National Cancer Institute) Tuesday, March 8, 2022 87 FR 12968